Morgan Stanley lowered the firm’s price target on Elanco (ELAN) to $13 from $14 and keeps an Equal Weight rating on the shares. Q4 EPS of 14c was “slightly” below consensus and the company issued “respectable” initial 2025 constant currency guidance, the analyst tells investors.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELAN:
- Elanco price target lowered to $15 from $16 at Stifel
- Cautious Outlook for Elanco Animal Health Amid Lower EPS and EBITDA Projections
- Elanco price target lowered to $19 from $20 at Barclays
- Elanco Animal Health: Promising Growth Amid FX Challenges and Strong Product Pipeline
- Elanco Animal Health Reports 2024 Earnings and 2025 Outlook